<?phpxml version="1.0" encoding="utf-8"?>
<rss version="2.0" 
xmlns:content="http://purl.org/rss/1.0/modules/content/"
xmlns:wfw="http://wellformedweb.org/CommentAPI/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
>
<channel>
<title>2 Learn How / irispuma04 / Upvoted</title>
<link>http://2learnhow.com</link>
<description>Your Source for Social News and Networking</description>
<pubDate>Wed, 05 Jul 2023 05:56:26 +0000</pubDate>
<language>en</language>
<item>
	<title><![CDATA[ErcialNoDerivs 3.0 Unported License. The images or other third party material in]]></title>
	<link>http://2learnhow.com/story.php?title=ercialnoderivs-3-0-unported-license-the-images-or-other-third-party-material-in-5</link>
	<source url="http://2learnhow.com/story.php?title=ercialnoderivs-3-0-unported-license-the-images-or-other-third-party-material-in-5"><![CDATA[ErcialNoDerivs 3.0 Unported License. The images or other third party material in]]></source>
	<description><![CDATA[ErcialNoDerivs 3.0 Unported License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://cr ]]></description>
	<pubDate>Wed, 05 Jul 2023 05:56:26 +0000</pubDate>
	<author>irispuma04</author>
	<category></category>
	<votes>1</votes>
	<guid>http://2learnhow.com/story.php?title=ercialnoderivs-3-0-unported-license-the-images-or-other-third-party-material-in-5</guid>
</item>

<item>
	<title><![CDATA[ErcialNoDerivs 3.0 Unported License. The images or other third party material in]]></title>
	<link>http://2learnhow.com/story.php?title=ercialnoderivs-3-0-unported-license-the-images-or-other-third-party-material-in-9</link>
	<source url="http://2learnhow.com/story.php?title=ercialnoderivs-3-0-unported-license-the-images-or-other-third-party-material-in-9"><![CDATA[ErcialNoDerivs 3.0 Unported License. The images or other third party material in]]></source>
	<description><![CDATA[ErcialNoDerivs 3.0 Unported License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://cr ]]></description>
	<pubDate>Wed, 05 Jul 2023 05:55:49 +0000</pubDate>
	<author>irispuma04</author>
	<category></category>
	<votes>1</votes>
	<guid>http://2learnhow.com/story.php?title=ercialnoderivs-3-0-unported-license-the-images-or-other-third-party-material-in-9</guid>
</item>

<item>
	<title><![CDATA[Infection in vitro, this protein was tested for clinical efficacy in]]></title>
	<link>http://2learnhow.com/story.php?title=infection-in-vitro-this-protein-was-tested-for-clinical-efficacy-in-4</link>
	<source url="http://2learnhow.com/story.php?title=infection-in-vitro-this-protein-was-tested-for-clinical-efficacy-in-4"><![CDATA[Infection in vitro, this protein was tested for clinical efficacy in]]></source>
	<description><![CDATA[Infection in vitro, this protein was tested for clinical efficacy in HIV-1-infected individuals; however, no effect on plasma viral loads was observed [13]. Further examination revealed that doses of sCD4 that were significantly higher than those achieved in the clinical trial were required to neutralize primary clinical isolates of HIV-1, in contrast to the relatively sensitive, laboratory-adapte ]]></description>
	<pubDate>Mon, 03 Jul 2023 02:38:43 +0000</pubDate>
	<author>irispuma04</author>
	<category></category>
	<votes>1</votes>
	<guid>http://2learnhow.com/story.php?title=infection-in-vitro-this-protein-was-tested-for-clinical-efficacy-in-4</guid>
</item>

<item>
	<title><![CDATA[ErcialNoDerivs 3.0 Unported License. The images or other third party material in]]></title>
	<link>http://2learnhow.com/story.php?title=ercialnoderivs-3-0-unported-license-the-images-or-other-third-party-material-in-9</link>
	<source url="http://2learnhow.com/story.php?title=ercialnoderivs-3-0-unported-license-the-images-or-other-third-party-material-in-9"><![CDATA[ErcialNoDerivs 3.0 Unported License. The images or other third party material in]]></source>
	<description><![CDATA[ErcialNoDerivs 3.0 Unported License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://cr ]]></description>
	<pubDate>Thu, 29 Jun 2023 04:18:14 +0000</pubDate>
	<author>irispuma04</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://2learnhow.com/story.php?title=ercialnoderivs-3-0-unported-license-the-images-or-other-third-party-material-in-9</guid>
</item>

<item>
	<title><![CDATA[Amic changes in conformation and function of the HIV-1 envelope glycoproteins]]></title>
	<link>http://2learnhow.com/story.php?title=amic-changes-in-conformation-and-function-of-the-hiv-1-envelope-glycoproteins-8</link>
	<source url="http://2learnhow.com/story.php?title=amic-changes-in-conformation-and-function-of-the-hiv-1-envelope-glycoproteins-8"><![CDATA[Amic changes in conformation and function of the HIV-1 envelope glycoproteins]]></source>
	<description><![CDATA[Amic changes in conformation and function of the HIV-1 envelope glycoproteins, immediately after engagement of the activating molecules. Using these tools, we found that SCMs inactivate envelope glycoprotein function by an activation-triggered inhibition process, through induction of a metastable activated state.Materials and Methods Reagents and AntibodiesFour-domain sCD4 (molecular weight 50 kDa ]]></description>
	<pubDate>Thu, 29 Jun 2023 03:48:57 +0000</pubDate>
	<author>irispuma04</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://2learnhow.com/story.php?title=amic-changes-in-conformation-and-function-of-the-hiv-1-envelope-glycoproteins-8</guid>
</item>

<item>
	<title><![CDATA[Title Loaded From File]]></title>
	<link>http://2learnhow.com/story.php?title=title-loaded-from-file-6</link>
	<source url="http://2learnhow.com/story.php?title=title-loaded-from-file-6"><![CDATA[Title Loaded From File]]></source>
	<description><![CDATA[ErcialNoDerivs 3.0 Unported License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://cr ]]></description>
	<pubDate>Wed, 28 Jun 2023 04:05:18 +0000</pubDate>
	<author>irispuma04</author>
	<category></category>
	<votes>1</votes>
	<guid>http://2learnhow.com/story.php?title=title-loaded-from-file-6</guid>
</item>

<item>
	<title><![CDATA[Effects of inflammation on health during chronic HIV infection. Immunity 2013; 39: 633?45. 55. Kuller]]></title>
	<link>http://2learnhow.com/story.php?title=effects-of-inflammation-on-health-during-chronic-hiv-infection-immunity-2013-39-63345-55-kuller-9</link>
	<source url="http://2learnhow.com/story.php?title=effects-of-inflammation-on-health-during-chronic-hiv-infection-immunity-2013-39-63345-55-kuller-9"><![CDATA[Effects of inflammation on health during chronic HIV infection. Immunity 2013; 39: 633?45. 55. Kuller]]></source>
	<description><![CDATA[Effects of inflammation on health during chronic HIV infection. Immunity 2013; 39: 633?45. 55. Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, Lane HC et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 2008; 5: e203. 56. Neuhaus J, Jacobs Jr DR, Baker JV, Calmy A, Duprez D, La Rosa A et al. Markers of inflammation, coagulation, and renal func ]]></description>
	<pubDate>Mon, 26 Jun 2023 03:21:55 +0000</pubDate>
	<author>irispuma04</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://2learnhow.com/story.php?title=effects-of-inflammation-on-health-during-chronic-hiv-infection-immunity-2013-39-63345-55-kuller-9</guid>
</item>

<item>
	<title><![CDATA[ErcialNoDerivs 3.0 Unported License. The images or other third party material in]]></title>
	<link>http://2learnhow.com/story.php?title=ercialnoderivs-3-0-unported-license-the-images-or-other-third-party-material-in-5</link>
	<source url="http://2learnhow.com/story.php?title=ercialnoderivs-3-0-unported-license-the-images-or-other-third-party-material-in-5"><![CDATA[ErcialNoDerivs 3.0 Unported License. The images or other third party material in]]></source>
	<description><![CDATA[ErcialNoDerivs 3.0 Unported License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://cr ]]></description>
	<pubDate>Tue, 20 Jun 2023 02:42:14 +0000</pubDate>
	<author>irispuma04</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://2learnhow.com/story.php?title=ercialnoderivs-3-0-unported-license-the-images-or-other-third-party-material-in-5</guid>
</item>

<item>
	<title><![CDATA[ErcialNoDerivs 3.0 Unported License. The images or other third party material in]]></title>
	<link>http://2learnhow.com/story.php?title=ercialnoderivs-3-0-unported-license-the-images-or-other-third-party-material-in-2</link>
	<source url="http://2learnhow.com/story.php?title=ercialnoderivs-3-0-unported-license-the-images-or-other-third-party-material-in-2"><![CDATA[ErcialNoDerivs 3.0 Unported License. The images or other third party material in]]></source>
	<description><![CDATA[ErcialNoDerivs 3.0 Unported License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://cr ]]></description>
	<pubDate>Tue, 20 Jun 2023 02:41:34 +0000</pubDate>
	<author>irispuma04</author>
	<category></category>
	<votes>1</votes>
	<guid>http://2learnhow.com/story.php?title=ercialnoderivs-3-0-unported-license-the-images-or-other-third-party-material-in-2</guid>
</item>

<item>
	<title><![CDATA[ErcialNoDerivs 3.0 Unported License. The images or other third party material in]]></title>
	<link>http://2learnhow.com/story.php?title=ercialnoderivs-3-0-unported-license-the-images-or-other-third-party-material-in-9</link>
	<source url="http://2learnhow.com/story.php?title=ercialnoderivs-3-0-unported-license-the-images-or-other-third-party-material-in-9"><![CDATA[ErcialNoDerivs 3.0 Unported License. The images or other third party material in]]></source>
	<description><![CDATA[ErcialNoDerivs 3.0 Unported License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://cr ]]></description>
	<pubDate>Tue, 20 Jun 2023 02:37:40 +0000</pubDate>
	<author>irispuma04</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://2learnhow.com/story.php?title=ercialnoderivs-3-0-unported-license-the-images-or-other-third-party-material-in-9</guid>
</item>

<item>
	<title><![CDATA[ErcialNoDerivs 3.0 Unported License. The images or other third party material in]]></title>
	<link>http://2learnhow.com/story.php?title=ercialnoderivs-3-0-unported-license-the-images-or-other-third-party-material-in-7</link>
	<source url="http://2learnhow.com/story.php?title=ercialnoderivs-3-0-unported-license-the-images-or-other-third-party-material-in-7"><![CDATA[ErcialNoDerivs 3.0 Unported License. The images or other third party material in]]></source>
	<description><![CDATA[ErcialNoDerivs 3.0 Unported License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://cr ]]></description>
	<pubDate>Tue, 20 Jun 2023 02:36:52 +0000</pubDate>
	<author>irispuma04</author>
	<category></category>
	<votes>1</votes>
	<guid>http://2learnhow.com/story.php?title=ercialnoderivs-3-0-unported-license-the-images-or-other-third-party-material-in-7</guid>
</item>

<item>
	<title><![CDATA[ErcialNoDerivs 3.0 Unported License. The images or other third party material in]]></title>
	<link>http://2learnhow.com/story.php?title=ercialnoderivs-3-0-unported-license-the-images-or-other-third-party-material-in-9</link>
	<source url="http://2learnhow.com/story.php?title=ercialnoderivs-3-0-unported-license-the-images-or-other-third-party-material-in-9"><![CDATA[ErcialNoDerivs 3.0 Unported License. The images or other third party material in]]></source>
	<description><![CDATA[ErcialNoDerivs 3.0 Unported License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://cr ]]></description>
	<pubDate>Mon, 19 Jun 2023 02:53:02 +0000</pubDate>
	<author>irispuma04</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://2learnhow.com/story.php?title=ercialnoderivs-3-0-unported-license-the-images-or-other-third-party-material-in-9</guid>
</item>

<item>
	<title><![CDATA[ErcialNoDerivs 3.0 Unported License. The images or other third party material in]]></title>
	<link>http://2learnhow.com/story.php?title=ercialnoderivs-3-0-unported-license-the-images-or-other-third-party-material-in-7</link>
	<source url="http://2learnhow.com/story.php?title=ercialnoderivs-3-0-unported-license-the-images-or-other-third-party-material-in-7"><![CDATA[ErcialNoDerivs 3.0 Unported License. The images or other third party material in]]></source>
	<description><![CDATA[ErcialNoDerivs 3.0 Unported License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://cr ]]></description>
	<pubDate>Mon, 19 Jun 2023 02:52:29 +0000</pubDate>
	<author>irispuma04</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://2learnhow.com/story.php?title=ercialnoderivs-3-0-unported-license-the-images-or-other-third-party-material-in-7</guid>
</item>

<item>
	<title><![CDATA[Infection in vitro, this protein was tested for clinical efficacy in]]></title>
	<link>http://2learnhow.com/story.php?title=infection-in-vitro-this-protein-was-tested-for-clinical-efficacy-in-7</link>
	<source url="http://2learnhow.com/story.php?title=infection-in-vitro-this-protein-was-tested-for-clinical-efficacy-in-7"><![CDATA[Infection in vitro, this protein was tested for clinical efficacy in]]></source>
	<description><![CDATA[Infection in vitro, this protein was tested for clinical efficacy in HIV-1-infected individuals; however, no effect on plasma viral loads was observed [13]. Further examination revealed that doses of sCD4 that were significantly higher than those achieved in the clinical trial were required to neutralize primary clinical isolates of HIV-1, in contrast to the relatively sensitive, laboratory-adapte ]]></description>
	<pubDate>Mon, 12 Jun 2023 05:45:58 +0000</pubDate>
	<author>irispuma04</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://2learnhow.com/story.php?title=infection-in-vitro-this-protein-was-tested-for-clinical-efficacy-in-7</guid>
</item>

<item>
	<title><![CDATA[ErcialNoDerivs 3.0 Unported License. The images or other third party material in]]></title>
	<link>http://2learnhow.com/story.php?title=ercialnoderivs-3-0-unported-license-the-images-or-other-third-party-material-in-6</link>
	<source url="http://2learnhow.com/story.php?title=ercialnoderivs-3-0-unported-license-the-images-or-other-third-party-material-in-6"><![CDATA[ErcialNoDerivs 3.0 Unported License. The images or other third party material in]]></source>
	<description><![CDATA[ErcialNoDerivs 3.0 Unported License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://cr ]]></description>
	<pubDate>Wed, 07 Jun 2023 03:02:34 +0000</pubDate>
	<author>irispuma04</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://2learnhow.com/story.php?title=ercialnoderivs-3-0-unported-license-the-images-or-other-third-party-material-in-6</guid>
</item>

</channel>
</rss>
